Please use this identifier to cite or link to this item:
Title: Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.
Austin Authors: Jamieson, Gary P;Snook, M B;Bradley, T R;Bertoncello, I;Wiley, J S
Affiliation: Department of Haematology, Austin Hospital, Heidelberg, Melbourne, Australia
Issue Date: 15-Jan-1989
Publication information: Cancer Research; 49(2): 309-13
Abstract: 1-beta-D-Arabinofuranosylcytosine (araC) is an effective drug in the i.p. therapy of ovarian carcinoma but little is known of its transport and metabolism in this tumor. Influx of araC at 1 microM into cultured human ovarian carcinoma cells (CI 80-13S) was largely inhibited by nanomolar concentrations of the nucleoside transport inhibitor, nitrobenzylthioinosine, while the residual influx (approximately 10%) was inhibited only by micromolar concentrations of nitrobenzylthioinosine. There was a two fold greater density of specific [3H]nitrobenzylthioinosine binding to the nucleoside transporters on the ovarian than on cultured human leukemic cells (RC2a). Calculated turnover rates of the nucleoside transporter for 1 microM araC were 5-fold less in ovarian than in leukemic cells. The major metabolic product of araC was 1-beta-D-arabinofuranosylcytosine 5'-triphosphate (araCTP) which accumulated in the ovarian cells to levels half those achieved in the leukemic cells. AraC was the major product of araCTP degradation in ovarian cells consistent with a pathway (araCTP--------araCMP----araC) which is different from that previously found in leukemic cells (araCTP--------araCMP----araUMP----araU). Despite these differences, ovarian carcinoma cells show substantial accumulation of araCTP from extracellular araC.
Gov't Doc #: 2910450
Journal: Cancer research
Type: Journal Article
Subjects: Adenocarcinoma.metabolism
Arabinofuranosylcytosine Triphosphate.metabolism
Binding Sites
Cell Line
Leukemia, Myelomonocytic, Acute.metabolism
Ovarian Neoplasms.metabolism
Thioinosine.analogs & derivatives.metabolism
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.